Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Optimized CD19/CD22/CD3 antibody. Blood, 140 (16): 1750-1751 (October 2022)Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format, , , , , , and . OncoImmunology, 5 (11): e1238540 (2016)Bi- und trifunktionelle Antikörper-Fusionsproteine für die Krebsimmuntherapie : kumulative Habilitationsschrift. Universität Stuttgart, Stuttgart, Habilitationsschrift, (2016)IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer Immunotherapy, , , , and . Molecular Cancer Therapeutics, 18 (7): 1278-1288 (2019)Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans, , , , , and . Oncoimmunology, 7 (9): e1471442 (2018)Mechanosensory feedback loops during chronic inflammation, , and . Frontiers in cell and developmental biology, (2023)Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response, , , and . Cancer Immunology Immunotherapy, (2020)Tumor-targeted costimulation with antibody-fusion proteins improves bispecific antibody-mediated immune response in presence of immunosuppressive factors, , , and . Oncoimmunology, 6 (12): e1361594 (2017)Targeting of Epidermal Growth Factor Receptor (EGFR)-Expressing Tumor Cells with Sterically Stabilized Affibody Liposomes (SAL), , , , and . Bioconjugate Chemistry, 20 (6): 1201-1208 (2009)Antibody fusions with immunomodulatory proteins for cancer therapy. Pharmacology & therapeutics, (2015)